Acacetin and pinostrobin as a promising inhibitor of cancer-associated protein kinases
Acacetin and pinostrobin as a promising inhibitor of cancer-associated protein kinases
复制标题
DOI:
10.1016/j.fct.2021.112091
复制
发表时间:
2021-04-15
影响因子:
4.3
通讯作者:
Meena, Abha
中科院分区:
文献类型:
--
作者:
Singh, Shilpi;Meena, Ashish;Meena, Abha
Protein kinases associated with cancer genes play vital role in angiogenesis, invasion, motility, proliferation, and survival. Therefore, cancer prevention/treatment, targeting kinases with phytochemicals could be a promising approach. Given potential of phytochemicals in modulating cancer-associated kinases, present study aims to find inhibitory prospects of selected flavonoids for cancer-chemoprevention/treatment. The molecular docking interaction analysis was done by exploring binding potential of flavonoids with kinases (PI3K, Akt, mTOR, EGFR, MAPK, MKK4, Fyn, ZAP-70, B-Raf, JAK-2, STAT-1, STAT-3, STAT-4, STAT-5, and VEGF) involved in various carcinogenesis phases. Among flavonoids acacetin showed highest binding-energy against JAK-2 following Fyn > VEGF > PI3K > MKK4 > MAPK > BRaf > STAT-5 > STAT-1 > STAT-4 whereas pinostrobin depicts higher binding-energy with JAK-2 followed by B-Raf > MKK4 > VEGF > PI3K > MAPK > STAT-1 > STAT-4 > STAT-5. Further, molecular-dynamic simulation revealed that pinostrobin interacted with JAK-2 protein with binding-energy of 25.068 +/- 1.08 kJ/mol whereas acacetin interacted with both JAK-2 and Fyn with bindin-genergies of -23.466 +/- 0.9508 kJ/mol and -8.935 +/- 1.3108 kJ/mol respectively. High binding-energy, low inhibition-constant, and drug-likeness of acacetin and pinostrobin provide a clue for their usage as a JAK-2 inhibitor which could be useful for molecular/cell-target based in-vitro and in-vivo investigations.